Inventor · disambiguated record
Fariba Soleymanzadeh
Also filed as: SOLEYMANZADEH FARIBA
10 granted patents·14 pending applications·20 citations·filing 2003–2020
85Inventor score
Files withBOEHRINGER INGELHEIM INT14BOEHRINGER INGELHEIM PHARMA2COOK BRIAN NICHOLAS2BENTZIEN JOERG MARTIN1BOSANAC TODD1
Top patents by PatentIndex Score
24 records- 0187US10875852B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 29, 2020·2 cites·12 claims
- 0286US9975882B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 22, 2018·5 cites·40 claims
- 0382US10138229B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 0474US8697911B2Rho kinase inhibitorsCOOK BRIAN NICHOLAS·Filed 2011·Granted Apr 15, 2014·3 cites·12 claims
- 0572US9150577B2Heterocyclic compounds containing an indole coreBOYER STEPHEN J·Filed 2010·Granted Oct 6, 2015·4 cites·3 claims
- 0669US10570118B2Isoquinolones as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 25, 2020·1 cites·12 claims
- 0769US2021009567A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 0865US2020055843A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0964US8815857B2Soluble guanylate cyclase activatorsBOSANAC TODD·Filed 2012·Granted Aug 26, 2014·1 cites·15 claims
- 1063US2019092759A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1162US2018222893A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1261US9000154B2Rho kinase inhibitorsKIRRANE THOMAS MARTIN·Filed 2011·Granted Apr 7, 2015·1 cites·11 claims
- 1360US2014045813A1Heteroaromatic compounds as btk inhibitorsBENTZIEN JOERG MARTIN·Filed 2013·Application pending·0 cites
- 1460US2018030037A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1559US7115644B2Heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 3, 2006·1 cites·16 claims
- 1659US2017320867A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1754US2016031872A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1851US2011118262A1Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 InhibitiorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 1950US8258301B2Urotensin II receptor antagonistsCOOK BRIAN NICHOLAS·Filed 2008·Granted Sep 4, 2012·0 cites·3 claims
- 2045US2009111791A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 2143US2008280904A1N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase InhibitorsELDRUP ANNE BETTINA·Filed 2006·Application pending·0 cites
- 2243US2009099184A1Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 2343US2006276515A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameCYWIN CHARLES L·Filed 2006·Application pending·0 cites
- 2439US2005209284A1Tec kinase inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fariba Soleymanzadeh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →